COY
Asset Logo

Coppermoly Limited

🇦🇺 ASX

⛏️ MINING

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

+ 2.86%
Annual Growth

5 years average annual growth

💵

$ 500
Minimum Order

Due to regulatory requirements

🌏

0
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

Coppermoly Ltd. is an exploration and development company, which explores and evaluates copper, gold, molybdenum and gold deposits in Papua New Guinea. The company is headquartered in Brisbane, Queensland. The company went IPO on 2008-01-31. The Company’s projects are located in North Queensland (Australia). The firm is focused on copper and gold projects in the Mount Isa Inlier. The Company’s Mt Isa projects include two granted tenements and five applied tenements, four of them with IOCG potential are located within the Eastern Succession and one for Isa style copper system sits in the Western Foldbelt. The company holds contiguous EPM 27835 (Foxes Creek) and EPM 27836 (Mount Tracey), located over 55 km south southwest (SSW) of Cloncurry, and are situated along the north-south striking Cloncurry Fault. Its Windy Hill Prospect is located approximately 80 kilometers (km) south-west of Cloncurry. Its Jessievale application is located about 50 km north of Cloncurry. The application consists of 11 subblocks and sits next to its Mt Malakoff Project (EPM 28853).

📈 Performance

Price History

-9.56%

1M

1Y

10Y

Graph

Table

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$0.01

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in COY

0

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

N/A

💵 Average investment amount

N/A

Last time a customer invested in COY

N/A
COY investor breakdown
💵 Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

Less than 50k

👶 Age of investors

18 - 25

26 - 34

35 - 90

🙋 Legal gender of investors

Female

Male

Pearlers who invest in COY also invest in...

BetaShares Nasdaq 100 ETF

NDQ

NDQ.AX was created on 2015-05-26 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The fund aims to track the performance of the NASDAQ-100 Index (before fees and expenses). The NASDAQ-100 comprises 100 of the largest non-financial companies listed on the NASDAQ market, and includes many companies that are at the forefront of the new economy.

🙌 Performance (5Yr p.a)

25.73%

📊 Share price

$47.45 AUD

🤖 TECHNOLOGY

📈 HIGH PRICE GROWTH

Find Out More

Minbos Resources Ltd. engages in the exploration and development of phosphate mineral properties. The company is headquartered in Subiaco, Western Australia. The company went IPO on 2010-10-18. The firm is engaged in the nutrient supply and distribution business. The firm is focused on the development of a primary phosphate and nitrogen-based fertilizer business that stimulates agricultural production and promotes food security in Angola and the broader Congo Basin. The company is primarily focused on the development of the Cabinda Phosphate Project and the Capanda Green Ammonia Project. Its phosphate fertilizer brand is Prosper Primeiro. The Capanda Green Ammonia Project supplies nitrogen in the grow to sell sector in Angola.

🙌 Performance (5Yr p.a)

39.00%

📊 Share price

$0.06 AUD

📈 HIGH PRICE GROWTH

⛏️ MINING

Kuniko Ltd. engages in mineral exploration project developer targeting metals for electromobility, including copper, nickel and cobalt. The company is headquartered in Perth, Western Australia. The company went IPO on 2021-08-24. The firm is focused on the development of copper, nickel, and cobalt projects in Scandinavia and has expanded its interests to include prospects for lithium in Canada. Its key assets, located in Norway and Canada include Skuterud Cobalt Project, Ringerike Battery Metals Project, Undal-Nyberget Copper Project, Vaga Copper Project, Gullklumpan Copper Project, Nemaska South Lithium Project, Fraser Lithium Project, and Mia North Lithium Project. The Skuterud Cobalt Project is in central-southern Norway, due west of Oslo. Ringerike Battery Metals Project is about 15 kilometers (km) from Skuterud and the Ringerike licenses comprise about 360 square kilometers of exploration area, prospective for nickel, copper, and cobalt. Undal-Nyberget Copper Project is in the Roros Copper region. Vaga Copper Project includes anomalies. Fraser Lithium Project is about 150 square kilometers of exploration area with mapped pegmatites containing spodumene.

📊 Share price

$0.17 AUD

⛏️ MINING

URNM.AX was created on 2022-06-08 by BetaShares. The fund's investment portfolio concentrates primarily on theme equity. The investment objective of the BetaShares Global Uranium ETF is to provide an investment return that aims to track the performance of the Indxx North Shore Uranium Mining Index (the Index), before taking into account fees and expenses.

📊 Share price

$9.31 AUD

⚡️ ENERGY

WIRE.AX was created on 2022-11-23 by Global X. The fund's investment portfolio concentrates primarily on materials equity. The ETF currently has 260.97m in AUM and 41 holdings. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the Solactive Global Copper Miners Total Return Index.

📊 Share price

$13.05 AUD

⚖️ HIGH GOVERNANCE

🧱 MATERIALS

Want more shares? Try these...

COSOL Ltd. engages in the provision of information technology services. The company is headquartered in Brisbane, Queensland. The company went IPO on 2020-01-24. The company offers a range of solutions in Asset Management as a Service (AMaaS), Enterprise Asset Management as a Service, Asset Information Ecosystem Roadmaps, EAM/ERP Market Assessment, Data Quality Assessment, RPConnect, Application Managed Support, OnPlan Digital Work Management, Work Stream Manager, and Asset Management Learning Academy. AMaaS enables asset-intensive organizations to outsource their asset management operations to the Company and achieve a consumption-based maintenance solution and optimization across the people, process, systems and data elements of asset management. EAM/ERP Market Assessment assists asset-intensive organizations in reviewing, which EAM/ERP systems would suit their needs and objectives. RPConnect is a suite of data management modules.

📊 Share price

$0.87 AUD

🤖 TECHNOLOGY

CLEO Diagnostics Ltd. is a medical diagnostics/devices company which mainly focuses on the development of non-invasive blood based IVD tests to detect the presence, and recurrence, of ovarian cancer. The company is headquartered in Melbourne, Victoria. The company went IPO on 2023-08-22. Its principal activities involve the development and patent of a blood test for the detection of ovarian cancer. The company focuses on bringing to market a blood test for the early diagnosis of ovarian cancer based on the novel CXCL10 biomarker, which is produced early and at high levels by ovarian cancers but is largely absent in non-malignant disease. The company is advancing the availability of its blood test, under a modular execution strategy, which is designed to address all ovarian cancer detection markets with specific tests, including surgical triage, recurrence, high risk, and early-stage screening. The company has developed a three-phased product development strategy that delivers three related tests for ovarian cancer detection: Triage Test, Recurrence Test, and Screening Test. Triage Test is a pre-surgical test to determine the likelihood that a pre-surgical ovarian mass in a patient not yet referred to an oncologist, is malignant.

📊 Share price

$0.35 AUD
Compare
Add to watchlist